MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective effects of coffee ingredients against rotenone-induced neurodegeneration in parkinsonian model

I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, Y. Kitamura, M. Asanuma (Okayama, Japan)

Meeting: 2018 International Congress

Abstract Number: 193

Keywords: Caffeine, Experimental therapeutics, Rotenone

Session Information

Date: Saturday, October 6, 2018

Session Title: Neuropharmacology

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: In this study, we examined neuroprotective effects of coffee ingredients, caffeic acid (CA) and chlorogenic acid (CGA), against rotenone-induced neurodegeneration using primary cultured cells and parkinsonian mice.

Background: Epidemiological analyses showed that daily drinking coffee and teas decreases the risk of Parkinson’s disease to 40-50%. Among coffee ingredients, CA has catechol structure and its ester with quinic acid, CGA exerts antioxidative properties. Rotenone as a pesticide, mitochondrial complex I inhibitor, has been used to reproduce neurodegeneration of enteric nervous system that precedes nigral dopaminergic neuronal loss.

Methods: Male C57BL/6J mice were chronically subcutaneously administered with low dose rotenone (2.5 mg/kg/day) for 4 weeks using an osmotic mini pump. The animals were daily orally treated with CA or CGA for 1 week before rotenone exposure and during 4-week rotenone infusion, totally for 5 weeks. Brain and intestinal sections were immunostained by antibodies for tyrosine hydroxylase (TH), β-tubulin III and GFAP. Primary cultured enteric neurons and glial cells were prepared from the intestine of Sprague-Dawley rat embryos at 15 days gestation. Cells were treated with CA or CGA for 24 h in advance, and then exposed to rotenone for 48 h.

Results: Chronic subcutaneous administration of rotenone reduced the number of TH-positive cells in the substantia nigra and immunoreactivities of β-tubulin III and GFAP in the intestinal myenteric plexus of mice. Daily administrations of CA or CGA inhibited rotenone-induced damage of not only nigral dopaminergic neurons but also enteric neurons and glial cells. In primary cultured cells, low dose rotenone promoted dose-dependent reduction of β-tubulin III-positive enteric neurons in the neuron-glia cocultured system but not in the enriched enteric neuronal culture. Furthermore, treatment with CA or CGA markedly prevented rotenone-induced cell loss of enteric neurons and astrocyte-like glial cells.

Conclusions: These results suggest that intake of coffee ingredients CA and CGA prevents rotenone-induced neurodegeneration in both of the brain and myenteric plexus.

To cite this abstract in AMA style:

I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, Y. Kitamura, M. Asanuma. Neuroprotective effects of coffee ingredients against rotenone-induced neurodegeneration in parkinsonian model [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-coffee-ingredients-against-rotenone-induced-neurodegeneration-in-parkinsonian-model/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-effects-of-coffee-ingredients-against-rotenone-induced-neurodegeneration-in-parkinsonian-model/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley